Dr. Yehuda Handelsman | yehudahandelsman

A leading physician and top endocrinologist

in Los Angeles, California, and the United States.

MEET DR. YEHUDA HANDELSMAN, MD, FACP, FNLA, FASPC, FAHA, MACE

Dr. Yehuda Handelsman is a distinguished endocrinologist practicing privately in Tarzana, CA. He employs a tailored approach using state-of-the-art comprehensive interventions to prevent and manage obesity. diabetes, lipid disorders and other metabolic conditions. By providing preventive, rather than reactionary care, Dr. Handelsman works to keep these disorders from progressing into cardiovascular disease, heart failure, and kidney disease. He was names the top diabetes specialist in California and consistently ranks in the top 20 in the U.S. along with holding international recognition. With over 25 years of experience, his innovative approach to diabetes, obesity, weight loss and complications - backed by groundbreaking national guidelines which he pioneers - sets him apart from approaches that treat just surface-level symptoms. Additionally, Dr. Handelsman addresses thyroid disorders, nodules, and cancer, bone loss/osteoporosis, adrenal conditions, pituitary abnormalities, and sexual hormones deficiencies and excess. By choosing Dr. Handelsman, patients receive personalized expert care tailored to their specific needs, benefiting from his extensive knowledge, experience, compassion, and commitment to total health and well being.

Biography

Yehuda Handelsman, MD, FACP, FNLA, FASPC, FAHA, MACE

Medical Director & Principal Investigator, The Metabolic Institute of America

Medical Director & Principal Investigator, Metabolic Institute of America
Chair Scientific Advisory Board, Diabetes Cardiorenal & Metabolism Institute – DCMi, a Think Tank
Chair & Program Director, World Congress on Insulin Resistance, Diabetes & CVD
Chair & Program Director, The Heart in Diabetes Medical Conference & Initiative
Chair, DCRM- Multispecialty Practice Recommendations for the management of

diabetes, cardiorenal, and metabolic diseases

Chair, The Early Intervention and Intensive Therapy in T2D & CardioRenalMetabolic Diseases- Consensus Development. A DCMi Initiative
Past President, AACE, American College of Cardiology (ACE) & Pacific Lipid Association
Master of the American College of Endocrinology, Fellow of the American Society of Preventive Cardiology (ASPC), The National Lipid Association (NLA) and the American College of Physicians
Chair & Founder, International Committee for Insulin Resistance
Chair & Founder, International Lipid Forum (ILF) & Editor The Lipid Forum
Chair and member of various American Association of Clinical Endocrinologists (AACE) guidelines, algorithms, positions and consensuses on Comprehensive Diabetes Management, Lipids, CGM and Pumps
An associate editor of the Journal of Diabetes, member editorial panel of “European Medical Journal – Diabetes,” Editorial Advisory Board “Clinical Endocrinology News” and Editorial Board- “Endocrine Today.” Served as guest editor of several peer-reviewed journal
Has published over 150 peer-reviewed original research & review papers, position and consensus statements, editorials, clinical practice guidelines, books’ chapters and his Book “Clinical Management of Cardiovascular Risk in Diabetes and Obesity” is Published by Professional Communications, Inc.
Listed repeatedly in “The Leading Physicians of the world,” “Best Doctors of America.” “America’s Best Physicians,” “Top Doctors of Los Angeles,” & “Southern California Super Doctors.”

CV

Full Bio

Short Bio